Affimed (AFMD) Misses Q1 EPS by 2c

Affimed (NASDAQ: AFMD) reported Q1 EPS of (EUR0.21), EUR0.02 worse than the analyst estimate of (EUR0.19). Revenue for the quarter came in at EUR4.51 million versus the consensus estimate of EUR5.63 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• RH (RH) Tops Q1 EPS by 12c